Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
Graphic: 108 dots showing New York measles cases, 92 highlighted as reported since 15 July across 18 counties
  • Industry Insights
5 hours ago5 hours ago

New York Governor to Seek Federal Help on Measles Outbreak

The New York measles outbreak has 108 cases as Governor Hochul seeks HHS and CDC help after Kennedy offered support. What is confirmed so far.

  • Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed
  • City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO
  • Korea Medical Tourism Tops 2 Million as Health Checkups Boom
Graphic: magnifying glass over four tiles showing the HHS vaccine injury initiative moves, NIH clinic, CMS proposal, VAERS update and health records
  • Industry Insights
5 hours ago5 hours ago

Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed

The vaccine injury initiative from HHS Secretary Kennedy adds an NIH clinic, VAERS changes and a CMS proposal. See what is known and what is not.

  • New York Governor to Seek Federal Help on Measles Outbreak
  • City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO
  • Korea Medical Tourism Tops 2 Million as Health Checkups Boom
Graphic: City Therapeutics IPO at a valuation of up to $956.3 million, with a city skyline and a ticker banner for CTY
  • Industry Insights
5 hours ago5 hours ago

City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO

The City Therapeutics IPO targets a valuation of up to about $956 million at $17 to $19 a share. Terms, RNAi pipeline, financials and risks.

  • New York Governor to Seek Federal Help on Measles Outbreak
  • Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed
  • Korea Medical Tourism Tops 2 Million as Health Checkups Boom
Graphic: Teva Weltruza once-monthly olanzapine injection approved by the FDA, with a calendar showing one injection a month
  • Pharmaceuticals
5 hours ago4 hours ago

Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza

Weltruza FDA approval gives Teva a once-monthly subcutaneous olanzapine injection for adults with schizophrenia. Doses, trial data, safety, launch.

  • WHO Launches Global Roadmap to Tackle Hypertension in Pregnancy
  • Change Lifestyle Before Giving Children Weight-Loss Medication, WHO Says
  • AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease
  • Industry Insights

Digital Pathology Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 5 hours ago5 hours ago
  • Lifestyle and Wellness

Rising Zika Virus Cases in Pune Sparks Alarming Concerns: Total Infections Reach 19

Megan Wood 5 hours ago5 hours ago
Graphic: 108 dots showing New York measles cases, 92 highlighted as reported since 15 July across 18 counties
  • Industry Insights

New York Governor to Seek Federal Help on Measles Outbreak

Megan Wood5 hours ago5 hours ago014 mins

The New York measles outbreak has 108 cases as Governor Hochul seeks HHS and CDC help after Kennedy offered support. What is confirmed so far.

Read More
Graphic: magnifying glass over four tiles showing the HHS vaccine injury initiative moves, NIH clinic, CMS proposal, VAERS update and health records
  • Industry Insights

Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed

Megan Wood5 hours ago5 hours ago014 mins

The vaccine injury initiative from HHS Secretary Kennedy adds an NIH clinic, VAERS changes and a CMS proposal. See what is known and what is not.

Read More
Graphic: City Therapeutics IPO at a valuation of up to $956.3 million, with a city skyline and a ticker banner for CTY
  • Industry Insights

City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO

Megan Wood5 hours ago5 hours ago012 mins

The City Therapeutics IPO targets a valuation of up to about $956 million at $17 to $19 a share. Terms, RNAi pipeline, financials and risks.

Read More
Graphic: Teva Weltruza once-monthly olanzapine injection approved by the FDA, with a calendar showing one injection a month
  • Pharmaceuticals

Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza

Megan Wood5 hours ago4 hours ago011 mins

Weltruza FDA approval gives Teva a once-monthly subcutaneous olanzapine injection for adults with schizophrenia. Doses, trial data, safety, launch.

Read More
Graphic: WHO roadmap on hypertension in pregnancy, with a ring showing 16 percent of maternal deaths and chips for 42,000 deaths a year
  • Pharmaceuticals

WHO Launches Global Roadmap to Tackle Hypertension in Pregnancy

Megan Wood5 hours ago5 hours ago011 mins

Hypertension in pregnancy is linked to about 42,000 maternal deaths a year. What the new WHO global roadmap covers and what is missing.

Read More
Graphic: about 2.01 million foreign patients in South Korea in 2025, beside a health checkup card listing blood tests and ultrasound
  • Industry Insights

Korea Medical Tourism Tops 2 Million as Health Checkups Boom

Megan Wood5 hours ago4 hours ago012 mins

Korea medical tourism drew about 2.01 million foreign patients in 2025, with blood tests and ultrasounds booming. See the data and the caveats.

Read More
Graphic: 69 Karnataka MLAs claimed Rs 7.47 crore in medical reimbursements between May 2023 and September 2026, RTI data
  • Industry Insights

69 Karnataka MLAs Claimed ₹7.47 Crore in Medical Bills, RTI Data Shows

Megan Wood1 day ago4 hours ago011 mins

Karnataka MLAs medical bills: RTI data shows 69 MLAs claimed ₹7.47 crore from 2023 to 2026. Top claims, the rules and what is unknown.

Read More
Graphic: Healthleap raises $38M, with flagged hospital inpatients highlighted among a grid of patients
  • Healthcare IT

Healthleap Raises $38M for Its AI That Flags Hospital Patients Who May Need a Closer Look

Megan Wood1 day ago4 hours ago012 mins

Healthleap funding totals $38M in seed and Series A money for AI that screens hospital inpatients for malnutrition and delirium. Claims and caveats.

Read More
Graphic of WHO childhood obesity guidance: lifestyle only under 10, medicine considered at 10 to 19 after lifestyle care, surgery only in severe cases
  • Pharmaceuticals

Change Lifestyle Before Giving Children Weight-Loss Medication, WHO Says

Megan Wood1 day ago4 hours ago011 mins

WHO childhood obesity guidelines rule out weight-loss drugs under 10 and put lifestyle care before medicine for teens. What families should know.

Read More
  • 1
  • 2
  • 3
  • …
  • 43

Categories

  • Healthcare IT (14)
  • Industry Insights (297)
  • Lifestyle and Wellness (21)
  • Medical Devices (18)
  • Pharmaceuticals (38)
  • Uncategorized (1)

Recent Posts

  • New York Governor to Seek Federal Help on Measles Outbreak
  • Kennedy Launches New Push on Vaccine Injuries: What HHS Revealed
  • City Therapeutics Eyes Valuation of Up to $956.3 Million in US IPO
  • Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
  • WHO Launches Global Roadmap to Tackle Hypertension in Pregnancy

You May Have Missed

Six children die of suspected Chandipura virus infection in Gujarat
  • Lifestyle and Wellness

Chandipura Virus Infection Claims 6 Children

Megan Wood 2 years ago2 years ago
Clinical Analytics Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

Clinical Analytics Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 4 months ago
Wearable Neurostimulation Devices Market
  • Industry Insights

Wearable Neurostimulation Devices Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 8 months ago
Electron Microscope Sample Preparation Market
  • Industry Insights

Electron Microscope Sample Preparation Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 7 months ago
AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035
  • Industry Insights

AI in Healthcare Market Revenue, Trends, and Strategic Insights by 2035

Megan Wood 4 months ago4 months ago
Medical Disposables Market Revenue, Trends, and Strategic Insights by 2030
  • Industry Insights

Medical Disposables Market Revenue, Trends, and Strategic Insights by 2030

Megan Wood 4 months ago
roche fenebrutinib fda priority review ms
  • Uncategorized

FDA Accepts Roche’s Fenebrutinib NDA with Priority Review for Relapsing and Primary Progressive MS

Megan Wood 1 week ago4 hours ago
Mitochondrial Disease Therapeutics Market Revenue, Trends, and Strategic Insights by 2032
  • Industry Insights

Mitochondrial Disease Therapeutics Market Revenue, Trends, and Strategic Insights by 2032

Megan Wood 5 months ago
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.